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Abstract
Adult articular cartilage presents poor intrinsic capacity for regeneration, 
and after injury, cellular or biomaterial-based therapeutic platforms are required 
to assist repair promotion. Cartilage tissue engineering (CTE) aims to produce 
cartilage-like tissues that recreate the complex mechanical, biophysical and 
biological properties found in vivo. In terms of biomaterials used for CTE, three-
dimensional (3D) self-assembling peptide scaffolds (SAPS) are very attractive for 
their unique properties, such as biocompatibility, optional possibility of rationally 
design cell-signaling capacity, biodegradability and modulation of its biomechani-
cal properties. The most attractive cell types currently used for CTE are autologous 
chondrocytes and adult stem cells. The use of chondrocytes in cell-based therapies 
for cartilage lesions is limited by quantity and requires an in vitro 2D expansion, 
which leads to cell dedifferentiation. In the present chapter, we report the develop-
ment of heparin-, chondroitin sulfate-, decorin-, and poly(ε-caprolactone)-based 
self-assembling peptide composite scaffolds to promote re-differentiation of 
expanded human articular chondrocytes and induction of adipose-derived stem 
cells to chondrogenic commitment.
Keywords: 3D cell culture, cartilage, self-assembling peptide scaffold, biomimetic 
materials, tissue engineering
1. Introduction
Articular cartilage is an avascular connective tissue, composed of chondrocytes 
as practically unique cell type. Articular chondrocytes synthesize, maintain and 
remodel the highly specialized extracellular matrix (ECM) [1], which in turn allows 
to withstand the mechanical requirements of the joints [2]. It is currently believed 
that due to its avascular nature, cartilage tissue lacks an intrinsic capacity for regen-
eration in response to disease or injury, leading to long-term pain, degeneration and 
loss of function [3]. Cartilage tissue engineering (CTE) aims to produce cartilage-
like tissue substitutes by combining the appropriate cells, scaffolds and bioactive 
molecules to assist repair cartilage lesions [4, 5].
Cell types currently used for CTE include autologous articular chondrocytes 
(ACh), which already possess the desired phenotype, and mesenchymal stem 
cells (MSC), from bone marrow (BMSC) or adipose tissue-derived (ADSC), 
which can be induced to undergo chondrogenic differentiation [6, 7]. Autologous 
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chondrocytes would be the ideal cell source for cartilage repair due to their intrinsic 
properties regarding cell function and immune compatibility. However, cell acces-
sibility from a patient biopsy is limited, and once isolated, chondrocytes needs to 
be extensively expanded in 2D monolayer [1]. During expansion process, chon-
drocytes rapidly undergo extensive loss of the original tissue-specific phenotype, 
downregulating the expression of chondrogenic markers, such as collagens and 
glycosaminoglycans while acquiring a fibroblast-like phenotype [8, 9].
Three-dimensional (3D) culture platforms are currently used to restore or main-
tain chondrogenic phenotype, since it recreates more closely the complex cellular 
microenvironment found in vivo [10, 11]. In terms of biomaterials used for CTE 
diverse possibilities in composition, structure, biodegradability and biomechanical 
properties exist. In general, biomaterials user for tissue engineering applications 
can be classified into natural or synthetic scaffolds. Natural scaffolds are commonly 
hydrogels made of natural materials such as Matrigel™, collagen type I, laminin and 
gelatin, which provide chemical cues, principally ECM binding motifs. However, 
due to its natural origin, they frequently contain undefined amounts of different 
constituents such as growth factors and cytokines which would be the main respon-
sible of presenting variability from batch to batch [10]. Thus, due to its complex 
composition possible modifications to improve them are limited. On the other 
hand, synthetic scaffolds have minimal variation from batch to batch production, 
providing a reproducible cellular microenvironment. Moreover, they present lower 
biodegradability in vitro, fact that permits to maintain structural and mechanical 
properties for longer periods of time. Alike natural scaffolds, structural properties, 
such as matrix stiffness, can be modulated by increasing concentration. In the last 
decades, polymeric scaffolds, such as poly(lactic-co-glycolic acid) (PLGA) [12] and 
polylactic acid (PLA) [13, 14] as well as synthetic peptide nanofibers [15] have been 
developed to culture cells in 3D. Clinically used scaffolds are collagen type I/III and 
hyaluronic acid-based biomaterials, and others under consideration are for instance 
injectable fibrin gels, collagen type I or II and sponges, polylactic acid (PLA) and 
polyglycolic acid (PGA). As today, however, the best CTE product does not main-
tain their tissue properties after implantation, and the minimal medical standards 
are not yet achieved.
Synthetic hydrogels are good candidates for CTE since they possess unique 
properties, such as more than 95% of water content (which mimics the native 
cartilage ECM), biocompatibility and capacity of rationally design chemical signal-
ing and biochemical properties. One of the best examples is the self-assembling 
peptide scaffold RAD16-I, commercially available as Puramatrix™. RAD16-I is a 
short peptide constituted by the sequence AcN-(RADA)4-CONH2, which alternates 
hydrophilic and hydrophobic amino acids (Figure 1A) [16]. The peptide undergoes 
self-assembly into a nanofiber network with antiparallel β-sheet configuration 
under physiological conditions (Figure 1B) [17]. The nanoscale architecture of the 
fiber network (around 10 nm diameter and 50–200 nm pore size) allows the cells 
to experiment a truly 3D environment (Figure 1C). Besides, biomolecules in such 
nanoscale environment diffuse slowly and are likely to establish a local molecular 
gradient. Non-covalent interactions allow cell growth, migration, contact with 
other cells, shape changes and a properly exposition of membrane receptors. 
Moreover, since stiffness can be controlled by changing peptide concentration these 
hydrogels can be tuned up to embed cells but not to entrap them [18].
Since the peptide scaffold does not contain signaling motifs, the environ-
ment can be considered non-instructive, from the point of view of cell receptor 
recognition/activation. However, the self-assembling peptide scaffold RAD16-I 
can be functionalized by solid-phase synthesis by extending at the N-termini with 
signaling motifs, such as ECM ligands for cell receptors, to trigger different cellular 
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responses [16, 19]. Several studies showed the capacity of RAD16-I to support cell 
maintenance of multiple cell types, including endothelial cells [20], hepatocytes 
[19, 21], fibroblasts [22], embryonic [23] and somatic stem cells [24, 25].
In the present chapter, we report the development of new bicomponent scaffolds 
based on the self-assembling peptide RAD16-I, for guiding chondrogenic differen-
tiation of both adipose-derived stem cells (ADSC) and expanded dedifferentiated 
human articular chondrocytes (hAChs).
On one hand, we took advantage of the versatility of RAD16-I to specifically add 
molecular cues for guiding chondrogenesis in order to develop more biomimetic 
scaffolds. Thus, the first approach was based on the addition of heparin (Hep) 
moieties to the peptide scaffold, forming a stable electrostatic-based composite 
made of heparin-self-assembling peptide hydrogel. The advantage of this bicom-
ponent scaffold is its natural capacity to retain heparin binding domain (HBD) 
containing growth factors (GFs), and thus, protecting them from degradation or 
denaturation [25]. Therefore, the non-instructive RAD16-I scaffold provides the 
structural 3D environment while the heparin moiety the binding structure to HBD-
containing GFs. Our second approach, was based on mimicking the native articular 
cartilage ECM while providing signaling moieties presented in mature cartilage. 
Glycosaminoglycans (GAGs) and proteoglycans (PGs) are structural components 
of the native cartilage ECM and influence the regulation of cell proliferation, 
migration and differentiation [26]. In particular, chondroitin sulfate (CS, a sulfated 
GAG usually found as a constituent of PGs) and decorin (a small PG, consisting of 
a protein core linked to a GAG chain, consisting of chondroitin sulfate or derma-
tan sulfate) [27, 28] molecules were added to the RAD16-I scaffold by mixing the 
components, obtaining a chondroitin sulfate- and decorin-based self-assembling 
peptide composite scaffold.
Finally, we combined the self-assembling peptide RAD16-I with a woven poly 
(ε-caprolactone) (PCL). 3D weaving can be used to create porous structures arranged 
in multiple layers of continuous fibers in three orthogonal directions [29]. Such 
scaffolds were engineered with predetermined properties aiming to reproduce the 
mechanical features of native articular cartilage. Moreover, PCL is a Food and Drug 
Figure 1. 
Peptide RAD16-I self-assembles into a nanofiber network. (A) Molecular model of peptide RAD16-I. Since the 
scaffold contains no signaling moieties, the environment is not instructive for cells. R = Arg; A = Ala; D = Asp. 
(B) Molecular model of the nanofiber developed by self-assembling RAD16-I molecules. The nanofiber is 
formed by a double tape of assembled RAD16-I molecules in antiparallel β-sheet configuration. (C) RAD16-I 
nanofiber network viewed by SEM. The nanoscale architecture of the fiber network) allows the cells to 
experiment a truly 3D environment white bar represents 200 nm. Adapted from Semino [17].
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Administration (FDA) approved biomaterial, biocompatible and biodegradable, 
widely used for medical applications [30, 31]. Our strategy was based on combine 
these two biomaterials to promote the attachment and differentiation of embed-
ded cells, providing at the same time a biomimetic mechanical environment of the 
native mature cartilage [32].
2. Materials and methods
2.1 2D culture of ADSC and hACh
ADSC (PT-5006, Lonza) were cultured in 175 cm2 T-flasks (<6th passage) in 
Adipose-Derived Stem Cell Basal Medium (ADSC-BM) (PT-3273, Lonza) supple-
mented with Adipose-Derived Stem Cell Growth Medium (ADSC-GM) SingleQuots 
(PT-4503, Lonza). hACh cells (CC-2550, Lonza) were cultured at 10,000 cells/cm2 
from passages 2–6 in 25, 75, and 175 cm2 T flasks. The growth medium consisted of 
Chondrocyte Basal Medium (CBM) (CC-3217, Lonza) plus SingleQuots of Growth 
Supplements (CC-4409, Lonza) containing R3-IGF-1, bFGF, transferrin, insulin, 
FBS, and gentamicin/amphotericin-B. Cultures were maintained in the incubator in 
humidified atmosphere at 37°C and 5% CO2.
2.2 3D culture of ADSC and hACh in RAD16-I composites scaffolds
ADSC and hACh 3D cultures were maintained under control or chondro-
genic conditions. Control medium was prepared with DMEM High Glucose, 
GlutaMAX (61965, Gibco), ITS + Premix 100x (354352, BDBioscience), 100 U/mL 
Penicillin/100 μg/mL Streptomycin (P11-010, PAA), 40 μg/mL l-Proline (P5607, 
Sigma) and 1 mM Sodium Pyruvate (11360, Life Technologies). Cultures for 
chondrogenic differentiation were induced at day 2 with chondrogenic medium 
(control medium supplemented with 10 ng/mL TGFβ1 (GF111, Millipore), 25 μg/mL 
l-ascorbic acid 2-phosphate (A8960; Sigma) and 100 nM Dexamethasone (D8893; 
Sigma)). Chondrocytes were also cultured in expansion medium (see Section 
2.1). 3D cell cultures were maintained in the incubator at 37°C and 5% CO2, and 
medium was changed every other day. Cultures were maintained for 4 weeks in the 
described serum-free media under control or chondrogenic conditions (in the pres-
ence of stimulating factors to induce chondrogenic differentiation) [33, 34]. After 
4 weeks, 3D constructs were analyzed for morphology, gene and protein expres-
sion, glycosaminoglycans production and mechanical properties.
2.3 ADSC 3D culture in RAD/heparin composite scaffold
RAD16-I (PuraMatrix™, 354250, Corning) and composites RAD/Hep were 
prepared at a final concentration of 0.3% (w/v) RAD16-I. The composites were 
prepared by combining 95 μL of 0.5% (w/v) RAD16-I and 5 μL of heparin sodium 
salt solution (H3149, Sigma) in a concentration range between 0.01% and 1% 
(w/v). The mixture was then diluted with 10% sucrose (S0389, Sigma) to a final 
concentration of 0.3% (w/v) RAD16-I. To obtain RAD and RAD/Hep 3D cultures, 
ADSC were harvested by trypsinization and resuspended to 4 × 106 cells/mL in 
10% sucrose. The 0.3% (w/v) RAD16-I peptide solution was mixed with the cell 
suspension (1:1) to obtain a final concentration of 0.15% (w/v) RAD16-I and 2 × 106 
cells/mL. Then, 80 μL of the cell-peptide mixture (160,000 cells) was loaded into 
individual wells of a 48-well culture containing 150 μL of medium, which induced 
the self-assembly of the peptide. The plate was placed in the incubator for 20 min 
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at 37°C and 5% CO2, and then 650 μL of fresh medium was added to the 3D cell 
cultures. ADSC 3D cultures were maintained during 2 days under control medium. 
Cultures for chondrogenic differentiation were induced at day 2 with chondrogenic 
medium.
2.3.1 ADSC and hACh 3D culture in RAD/CS and RAD/Dec composite scaffold
RAD16-I (PuraMatrix™, 354250, Corning) and composites RAD/CS and 
RAD/Decorin were prepared at a final concentration of 0.3% (w/v) RAD16-I. The 
composites were prepared by combining 95 μL of 0.5% (w/v) RAD16-I and 
5 μL CS or Decorin at a concentration of 0.2% (w/v). The mixture was then 
diluted with 10% sucrose (S0389, Sigma) to a final concentration of 0.3% (w/v) 
RAD16-I. To obtain RAD16-I, RAD/CS and RAD/Decorin 3D cultures, cells were 
harvested by trypsinization and resuspended to 4 × 106 cells/mL in 10% sucrose. 
The 0.3% (w/v) RAD16-I peptide solution was mixed with the cell suspension 
(1:1) to obtain a final concentration of 0.15% (w/v) RAD16-I and 2 × 106 cells/mL.  
Then, 80 μL of the cell-peptide mixture (160,000 cells) was loaded into indi-
vidual wells of a 48-well culture containing 150 μL of control or expansion 
medium, which induced the self-assembly of the peptide. The plate was placed in 
the incubator for 20 min at 37°C and 5% CO2, and then 650 μL of fresh medium 
was added to the 3D cell cultures.
2.3.2 hACh 3D culture in PCL, PCL/RAD and RAD scaffolds
In the case of PCL scaffold, a cell suspension of 25 × 106 cells/mL was seeded 
onto the surface of 5 mm × 0.75 mm woven PCL scaffolds (500,000 cells/scaffold). 
After 2 h, 100 μL of expansion or control medium were slowly added into the well 
and after 4 h, 700 μL were finally added. For PCL/RAD composites, cells were 
harvested and resuspended to 50 × 106 cells/mL in 10% (w/v) sucrose. Then, cells 
were equally mixed with 1% (w/v) RAD16-I and seeded onto the woven PCL scaf-
fold disks (500,000 cells/scaffold). Then, 40 μL of expansion or control medium 
was added and the gel was spontaneously formed inside the PCL scaffolds, where 
the cells were embedded. After 30 min, 60 μL of medium was added in the well, and 
after 2 h, 700 μL was finally added. 3D cell cultures were maintained in the incuba-
tor at 37°C and 5% CO2, and medium was changed every other day.
3. Representative results
Autologous chondrocytes are one of the most attractive cell types for CTE, 
due to their intrinsic properties regarding cell function, since they are found in 
the native cartilage. Chondrocytes are characterized by a rounded morphology, 
the production of tissue-specific ECM components such as collagen type I and II 
and glycosaminoglycans (GAGs). One of the main challenges in CTE is to obtain 
enough cell mass to develop a tissue construct with the desirable biological and 
biomechanical properties. Particularly, articular chondrocytes are obtained by 
invasive techniques and cell number in patient biopsies is limited. Therefore, after 
isolation, chondrocytes need to be expanded in 2D monolayer [1]. The expansion 
process leads to a rapid downregulation of chondrogenic markers, such as Collagen 
type I (COL1) collagen type II (COL2) and Aggrecan (ACAN) [8, 9]. Moreover, the 
use of extensively passaged cells leads to some degree of hypertrophy, decreased 
biochemical content and compromised mechanical properties [1], which is not a 
good indication for cartilage substitute applications.
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Mesenchymal stem cells (MSCs) have generated great interest as an alternative cell 
source to autologous chondrocytes. MSCs are pluripotent cells with a high prolifera-
tive capacity that can be differentiated, under the appropriate microenvironment, to 
numerous cell lineages, such as osteogenic, adipogenic and chondrogenic [35]. MSCs 
can be isolated from bone marrow, adipose tissue and other sources. In particular, 
the adipose tissue provides and abundant reservoir of mesenchymal stem cells 
(adipose-derived stem cells, ADSC), which can be obtained by non-invasive surgical 
techniques. ADSC can undergo chondrogenic commitment in the presence of TGF-β, 
ascorbate, and dexamethasone combined with a 3D culture environment [35].
Three-dimensional scaffold-based cell cultures are currently used in CTE to rees-
tablish chondrogenic phenotype of dedifferentiated chondrocytes, since they mimic 
more closely the natural tissue environment. On the other hand, differentiation of 
ADSC to cartilage-like tissue has been achieved in various 3D scaffold systems such 
as alginate [36], agarose [37] and collagen [38]. We report here the development of 
new bicomponent scaffolds based on the self-assembling peptide RAD16-I, for guid-
ing chondrogenic differentiation of both adipose-derived stem cells (ADSC) and 
expanded dedifferentiated human articular chondrocytes (hAChs).
3.1  Bicomponent scaffolds made out of heparin/self-assembling peptide 
hydrogels
In this section, we report the development of a nanofiber scaffold with growth 
factor binding affinity. The strategy consisted of adding heparin moieties to the 
RAD16-I peptide scaffold by mixing the two components, forming a stable com-
posite hydrogel scaffold with a natural capacity to retain HBD-containing growth 
factors. To evaluate the functionality of this approach for CTE applications, ADSC 
were cultured in the new bicomponent scaffold and induced to chondrogenic 
differentiation using TGFβ-1, l-ascorbic acid 2-phosphate and dexamethasone as 
inductors in serum-free media. 3D cultures were maintained for 4 weeks in chon-
drogenic or control medium, and analyzed for proteoglycan production, protein 
expression and mechanical properties.
During ADSC culture in the peptide scaffold RAD16-I combined with increasing 
concentrations of heparin (RAD/Hep), constructs cultured under chondrogenic 
medium—unlike constructs under control medium—became highly stained with 
toluidine blue, indicating a significant production of proteoglycans (Figure 2A). 
This result correlated with the aggrecan (ACAN) gene expression, which was only 
detected in constructs under chondrogenic induction (Figure 2B). ADSC cultured 
within RAD/Hep composites also produced cartilage-specific ECM proteins, such 
as COL1, COL2 and COL10 (Figure 2C). Interestingly, a single band was obtained 
for COL1 in 2D culture, corresponding probably to a pro-collagen intermediate 
(approx. 220 kDa). Different bands (ranging from 130 to 180 kDa) were obtained 
for COL1 in 3D constructs under chondrogenic induction. Importantly, COL2 was 
only detected in 3D chondro-induced cultures.
Moreover, mechanical characterization was performed over 3D chondro-induced 
constructs. 3D constructs, presented a storage modulus (G′) in the same order of 
magnitude to chicken or calf articular cartilage, but the full mechanical response of the 
constructs was different from native cartilage as evidenced by tan(delta) (Figure 2D).
3.2  Bicomponent scaffolds made out of chondroitin sulfate or decorin and self-
assembling peptide hydrogels
The next strategy was based on mimicking the native cartilage ECM by adding 
chondroitin sulfate or decorin molecules to the nanofiber scaffold, generating thus 
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chondro-favorable biochemical cues in the 3D environment. Previous work has 
evaluated the influence of CS to guide chondrogenesis in different hydrogel scaffolds 
such as chitosan [39], PEG [40], or collagen type I [41], but less is known about the 
ability of decorin to promote chondrogenesis commitment. In the present work, we 
studied the influence of both CS and decorin molecules on chondrogenesis in a nano-
metric 3D system. The capacity of these bicomponent scaffolds to foster chondro-
genic differentiation was evaluated in two different scenarios: re-differentiation of 
expanded hAChs and induction of ADSC to chondrogenic commitment. Cells were 
seeded in RAD16-I/CS, RAD16-I/Dec and RAD16-I scaffold alone and maintained 
for 4 weeks in chondrogenic or control medium. Moreover, chondrocytes were also 
cultured in expansion medium, which contains GFs that could affect the fate of the 
3D culture. 3D constructs were analyzed for morphology, gene and protein expres-
sion, proteoglycan synthesis and mechanical properties.
SEM images were obtained at week 4 of culture to assess cell morphology and 
their interaction with each scaffold (Figure 3). Articular chondrocytes cultured 
in expansion medium possessed a spherical morphology with possible cell-matrix 
interactions and thorough ECM components. Nanofibers and putative matrix 
components were detected on the surface of constructs cultured in control medium. 
Moreover, grooves with visible fibers were observed on the surface of constructs 
cultured in chondrogenic medium, fact that suggested the presence of secreted 
matrix components. On the other hand, adipose-derived stem cells under chon-
drogenic induction looked elongated and anchored to the scaffold surface, while 
Figure 2. 
Chondrogenic capacity of ADSC in RAD/heparin composite scaffold. ADSC were encapsulated within the 
RAD16-I peptide scaffold combined with increasing concentrations of heparin and cultured for 4 weeks under 
control and chondrogenic medium. (A) Toluidine blue staining of 3D ADSC constructs cultured under control 
and chondrogenic medium. 3D construct view scale bars = 500 μm and section close up scale bars = 100 μm. 
(B) Aggrecan gene expression levels of chondro-induced ADSC. Constructs cultured with control medium 
did not express aggrecan after 4 weeks of culture. Ct values relative to ribosomal protein L22 (RPL22) were 
obtained and reported as fold increase (ΔΔCt) relative to 2D cultures. (C) Protein expression characterization 
of ADSC cultured in RAD/Hep composites and in 2D monolayer. Western blot results of collagen type I, II and 
X when ADSC were maintained in control and chondrogenic medium in RAD16-I scaffold and RAD16-I/Hep 
composites. Actin expression was used as an internal control. (D) Mechanical characterization of 3D constructs 
cultured for 4 weeks in chondrogenic medium compared to chicken and calf articular cartilage. ADSCs cultured 
with RAD16-I and RAD/Hep composite scaffolds were analyzed for storage modulus (G′, A), loss modulus 
(G″, B), complex modulus (G*, C) and tan(delta). Significant differences are indicated as * for p < 0.05, ** for 
p < 0.01, and *** for p < 0.001, one-way ANOVA, N = 2 n = 3). Adapted from Fernández-Muiños et al. [25].
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nanofibers and possible ECM components synthesized by the cells were observed 
in control medium (Figure 3). No significant differences in cell morphology were 
detected between RAD, RAD/CS or RAD/Dec scaffolds in any cell type.
Chondrogenic markers expression were studied at gene and protein level 
in hACh 3D constructs cultured in chondrogenic and expansion medium, and 
compared to their 2D counterparts. COL1 was upregulated in all 3D scaffolds under 
chondrogenic medium and downregulated under expansion medium (Figure 4A). 
At protein level, COL1, was detected both in 2D monolayer and 3D constructs, but 
different band patterns were observed (Figure 4B). In 2D cultures, a single band 
was detected (approx. 220 kDa), generated probably by a pro-collagen intermedi-
ate. In 3D cultures, different bands of lower molecular weight (ranging from 130 
to 180 kDa) were observed, but their intensity varied depending on the culture 
medium.
Interestingly, COL2 gene expression was only upregulated in RAD/CS and 
RAD/Dec composite scaffolds under chondrogenic medium. This result correlated 
with the expression of SOX9, a gene regulator of COL2, which was significantly 
upregulated in 3D constructs under chondrogenic induction (Figure 4A). At 
protein level, COL2 was only detected in 3D cultures under chondrogenic induc-
tion, fact that was consistent with the gene expression profile results (Figure 4B). 
ACAN gene expression was higher in constructs under chondrogenic medium than 
in constructs cultured under expansion medium (Figure 4A). No differences were 
detected in the gene expression of hypertrophic markers compared to 2D cultures, 
except in RAD16-I scaffold alone, where the expression of COL10 was upregulated 
in expansion medium, and RUNX2 in chondrogenic medium (Figure 4A). COL10 
protein expression was observed in all conditions, including 2D, but more intense 
bands were detected in expansion and chondrogenic medium, compared to control 
(Figure 4B).
Toluidine blue staining was performed in hACh 3D constructs to qualitatively 
assess the production of GAGs. Constructs under chondrogenic induction became 
highly stained, indicating a significant production and accumulation of GAGs by 
the cells (Figure 4C). Constructs cultured under expansion medium showed less 
staining, while constructs under control medium became weakly stained.
Figure 3. 
SEM images of hACh and ADSC at week 4 of culture in RAD, RAD/CS and RAD/Dec scaffolds. Two images 
per condition are shown. Adapted from Recha-Sancho and Semino [42].
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The mechanical properties of hACh 3D constructs cultured under chondrogenic 
medium were assessed at week 4 by dynamic mechanical analysis (DMA) and 
compared to calf and chicken articular cartilage (Figure 4D). hACh constructs 
exhibited lower storage modulus values (G′) than did the native cartilage samples. 
The viscous components (G″) and the complex modulus (G*) displayed a more 
similar tendency to cartilage controls. Nevertheless, all samples presented G′ values 
higher than G″ values, indicating that the constructs were more elastic than viscous. 
Tan(delta) showed that 3D constructs were comparable to chicken cartilage but 
differed from calf cartilage.
Chondrogenic and hypertrophic markers were studied in ADSC 3D constructs 
in the three scaffold types and compared to 2D monolayer culture. Results show 
that the gene expression of COL1 was downregulated in 3D cultures. However, the 
expression of COL2, SOX9 and ACAN was increased in 3D cultures compared to 
2D. The expression levels of the hypertrophic markers COL10 and RUNX2 in 3D 
cultures were maintained at comparable levels to 2D culture (Figure 5A). At protein 
level, ADSC under chondrogenic induction produced cartilage-specific ECM 
proteins such as COL1, COL2 and COL10 (Figure 5B). As happened for hACh, one 
single band was obtained for COL1 in 2D monolayer, while different bands of lower 
molecular weight were observed in 3D cultures. Interestingly, COL2 protein was 
only detected in 3D cultures.
Figure 4. 
Chondrogenic capacity of dedifferentiated hACh in RAD/CS and RAD/Dec 3D composite scaffolds. hACh 
were encapsulated within the RAD16-I peptide scaffold combined with chondroitin sulfate and decorin, 
and cultured for 4 weeks under expansion, control and chondrogenic medium. (A) Gene expression levels 
of chondrogenic and hypertrophic markers. hACh were analyzed by qRT-PCR for collagen type I (COL1), 
collagen type II (COL2), SOX9, aggrecan (ACAN), collagen type X (COL10) and RUNX2. Ct values relative 
to ribosomal protein L22 (RPL22) were obtained and reported as the fold increase (ΔΔCt) relative to 2D 
cultures (B) protein expression characterization of hACh cultured in RAD, RAD/CS and RAD/Dec composites 
and in 2D monolayer. Western blot results of collagen type I (COL1), II (COL2) and X (COL10) when hACh 
were maintained in expansion, control and chondrogenic media in the different scaffolds (RAD, RAD/CS and 
RAD/Dec) and in 2D monolayer. Actin expression was used as an internal control. Samples were prepared 
in triplicate. (C) Toluidine blue staining of hACh 3D RAD, RAD/CS and RAD/Dec constructs cultured in 
expansion, control and chondrogenic medium. Proteoglycan synthesis was qualitatively assessed by toluidine 
blue staining. (D) Mechanical characterization of 3D constructs cultured for 4 weeks in chondrogenic medium 
compared to chicken and calf articular cartilage. hACh cultured with RAD16-I and RAD/CS and RAD/Dec 
composite scaffolds were analyzed for storage modulus (G′), loss modulus (G″), complex modulus (G*) and 
tan(delta). Significant differences are indicated as * for p < 0.05, ** for p < 0.01, and *** for p < 0.001, one-way 
ANOVA, N = 2 n = 3). Adapted from Recha-Sancho and Semino [42].
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Chondro-induced ADSC produced sulfated glycosaminoglycans, as reveals the 
intense staining by toluidine blue (Figure 5C, up). No calcium mineralization, an 
indicator of hypertrophy, was detected by Von Kossa staining (Figure 5C, down).
The mechanical properties of ADSC cultured under chondrogenic conditions 
in RAD, RAD/CS and RAD/Dec were assessed by dynamic mechanical analysis 
(DMA) at week 4 (Figure 5D). The constructs presented a storage modulus (G′), 
viscous component (G″) and complex modulus (G*) closely related to chicken and 
calf cartilage. However, samples presented values of G′ much higher than G´´ so 
that the constructs were more elastic than viscous. Tan(delta) showed that the full 
mechanical response of the constructs was very similar to chicken cartilage but 
differed from calf cartilage.
In the present work, we aimed to induce chondrogenesis differentiation of both 
expanded hACh and ADSC in 3D bicomponent scaffolds made out of chondroitin sul-
fate or decorin and self-assembling peptide hydrogels. The expression of chondrogenic 
markers such as COL2, SOX9 and ACAN was increased in both cell types compared to 
monolayer cultures (Figures 4A and 5A). At protein level, western blot results showed 
a possible COL1 maturation process in 3D cultures of both cell types compared to 2D 
protein expression. In particular, the final mature COL1 product corresponds to the 
lower molecular weight band (130 kDa), which was absent in 2D cultures but predom-
inant in constructs under chondrogenic medium (Figures 4B and 5B). Importantly, 
Figure 5. 
Chondrogenic capacity of ADSC in RAD/CS and RAD/Dec 3D composite scaffolds. ADSC were encapsulated 
within the RAD, RAD/CS and RAD/Dec composite scaffolds and cultured for 4 weeks under control and 
chondrogenic medium. (A) Gene expression levels of chondrogenic and hypertrophic markers. ADSC were 
analyzed by qRT-PCR for collagen type I (COL1), collagen type II (COL2), SOX9, aggrecan (ACAN), collagen 
type X (COL10) and RUNX2. Ct values relative to ribosomal protein L22 (RPL22) were obtained and 
reported as the fold increase (ΔΔCt) relative to 2D cultures. (B) Protein expression characterization of ADSC 
cultured in RAD, RAD/CS and RAD/Dec composites and in 2D monolayer. Western blot results of collagen 
type I (COL1), II (COL2) and X (COL10) when ADSC were cultured under control and chondrogenic medium 
in the different scaffold types. Actin expression was used as an internal control. (C) Toluidine blue and Von 
Kossa staining of 3D ADSC constructs under chondrogenic induction. Proteoglycan synthesis was qualitatively 
assessed by toluidine blue staining (up) and calcium mineralization by Von Kossa staining (down). 
(D) Mechanical characterization of 3D constructs cultured for 4 weeks in chondrogenic medium compared to 
chicken and calf articular cartilage. ADSCs cultured with RAD16-I and RAD/CS and RAD/Dec composite 
scaffolds were analyzed for storage modulus (G′, A), loss modulus (G″, B), complex modulus (G*, C) and 
tan(delta). Significant differences are indicated as * for p < 0.05, ** for p < 0.01, and *** for p < 0.001, one-way 
ANOVA, N = 2 n = 3). Adapted from Recha-Sancho and Semino [42].
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COL2 expression was only detected in 3D cultures under chondrogenic induction. 
Moreover, GAG production and accumulation was confirmed by toluidine blue stain-
ing (Figures 4C and 5C). Altogether, these results indicate the synergistic effect of the 
3D culture system and the chemical inducers present in the chondrogenic medium in 
activating signaling pathways essentials for chondrogenic commitment, in terms of 
production of proteins and GAG components of the ECM. Finally, mechanical charac-
terization showed that the viscoelastic behavior of chondro-induced ADSC constructs 
was more similar to native cartilage than hACh constructs (Figures 4D and 5D). In 
resume, results until this section clearly indicate the chondro-inductive capacity of the 
modified scaffold which reinforce the development of biomimetic microenvironments 
to promote better tissue engineered cartilage substitutes.
3.3  Bicomponent scaffolds made out of PCL and self-assembling peptide 
hydrogels
Self-assembling peptide hydrogels provide a soft and permissive microenviron-
ment, allowing cells to migrate, extend cellular processes and contact with other 
cells. Nevertheless, the use of soft hydrogels for CTE can be challenging due to its 
low stiffness. One approach to address this issue is the use of composite scaffolds, 
comprising a microscale component to increase mechanical properties and a hydro-
gel component (of nanoscale dimension) to promote chondrogenesis. Woven 3D 
poly(ε-caprolactone) (PCL) resemble native cartilage mechanical properties and, 
due to its high wettability, can be infiltrated with a hydrogel matrix, such as fibrin, 
alginate, and poly-acrylamide [43–45]. In this study, we developed a unique com-
posite scaffold by infiltrating a 3D woven microfiber poly(ε-caprolactone) scaffold 
with the RAD16-I self-assembling peptide nanofiber to obtain a multi-scale func-
tional cartilage-like tissue. The chondrogenic capacity of this new bicomponent was 
evaluated with expanded dedifferentiated human articular chondrocytes.
The high wettability properties of the PCL scaffold (Figure 6A) allowed to 
easily introduce the cells suspended in the RAD16-I peptide solution between the 
Figure 6. 
SEM characterization of PCL/RAD and hACh constructs. (A) Water (left) and 0.5% RAD16-I solution 
(right) contact angle. The liquid was totally absorbed by the PCL scaffold (contact angle << 90°), indicating 
high wettability. (B) Surface view of PCL and PCL/RAD structure by SEM. 0.5% RAD16-I was lyophilized 
within the PCL scaffold. (C) hACh at week 4 of culture in PCL, PCL/RAD and RAD scaffolds. hACh were 
seeded in each scaffold and cultured in expansion, control and chondrogenic medium. Two images per condition 
are shown. Adapted from Recha-Sancho et al. [46].
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interweaving fibers of PCL scaffold (Figure 6B, left). Areas of RAD16-I peptide 
deposition could be observed within the organized woven morphology of the fiber 
scaffold (Figure 6B, right). Thus, cells were seeded in the composite PCL/RAD and 
in the two scaffolds independently, PCL and RAD, and maintained for 4 weeks in 
expansion, chondrogenic and control medium. 3D constructs were analyzed for 
morphology, gene and protein expression, proteoglycan synthesis and mechanical 
properties.
In order to evaluate cell morphology and their interaction with the scaf-
folds, SEM images of hACh cultured in PCL, PCL/RAD and RAD 3D scaffolds in 
expansion, control and chondrogenic medium were taken at week 4 of culture 
(Figure 6C). hACh seeded in PCL scaffolds looked elongated and growing on the 
surface of PCL fibers. Interestingly, more fibers were detected under chondrogenic 
induction, probably due to an increase in extracellular matrix components produc-
tion by the cells. In PCL/RAD constructs, cells seemed to be attached to the PCL 
fibers, with a more spherical morphology than in PCL scaffold alone, while hACh in 
RAD scaffolds presented in general a spherical shape.
Chondrogenic and hypertrophic markers were studied at gene and protein 
level at week 4 of culture in 3D scaffolds and compared to 2D cultures. COL1 was 
downregulated or maintained at 2D culture levels under expansion medium, while 
it increased in all 3D constructs under chondrogenic conditions (Figure 7A). At 
protein level a single band (~220 kDa) was obtained for COL1 in 2D culture, while 
different bands of lower molecular weight (ranging from 180 to 130 kDa) were 
observed in 3D cultures of PCL/RAD and RAD (in all medium tested) and PCL in 
chondrogenic conditions (Figure 7B).
The expression of COL2 was only increased in PCL/RAD and PCL scaffolds 
under chondrogenic induction, however, significant differences were only detected 
Figure 7. 
Chondrogenic capacity of dedifferentiated hACh in PCL, PCL/RAD and RAD scaffolds. hACh were seeded 
in each scaffold, and cultured for 4 weeks under expansion, control and chondrogenic medium. (A) Gene 
expression levels of chondrogenic and hypertrophic markers. hACh were analyzed by qRT-PCR for collagen 
type I (COL1), collagen type II (COL2), SOX9, aggrecan (ACAN), collagen type X (COL10) and RUNX2. 
Ct values relative to ribosomal protein L22 (RPL22) were obtained and reported as the fold increase (ΔΔCt) 
relative to 2D cultures. Significant differences are indicated as * for p < 0.05, ** for p < 0.01, and *** for 
p < 0.001, one-way ANOVA, N = 2 n = 3). (B) Protein expression characterization of hACh cultured in 
PCL, PCL/RAD and RAD scaffolds and in 2D monolayer. Western blot results of collagen type I (COL1), 
II (COL2) and X (COL10) when hACh were maintained in expansion, control and chondrogenic media in 
the different scaffolds and in 2D monolayer. Actin expression was used as an internal control. Samples were 
prepared in triplicate. (C) Toluidine blue staining of hACh 3D PCL, PCL/RAD and RAD constructs cultured 
in expansion, control and chondrogenic medium. Proteoglycan synthesis was qualitatively assessed by toluidine 
blue staining. Adapted from Recha-Sancho et al. [46].
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for RAD scaffold (Figure 7A). At protein level, COL2 was only detected in PCL/
RAD and PCL scaffolds under chondrogenic medium (Figure 7B). SOX9 was down-
regulated in PCL scaffolds in both culture medium and PCL/RAD in expansion 
medium. Nevertheless, it was maintained similar to 2D levels in PCL/RAD com-
posites under chondrogenic induction and in RAD scaffold (Figure 7A). Aggrecan 
(ACAN) gene expression was downregulated in all scaffolds under expansion 
medium and upregulated in all scaffolds under chondrogenic medium, even though 
no differences were detected relative to 2D cultures (Figure 7A). Hypertrophic 
markers COL10 and RUNX2 were upregulated in some constructs respect to base-
line. However, no significant increase for COL10 was detected in RAD and PCL/
RAD constructs under chondrogenic medium (Figure 7A). At protein level, COL10 
was detected in all samples (Figure 7B).
The production of sulfated glycosaminoglycans was qualitatively assessed by 
toluidine blue staining. Constructs under chondrogenic medium were the most 
strongly stained compared to expansion and control medium (Figure 7C).
Mechanical properties of the scaffolds alone and hACh 3D constructs were 
assessed by dynamic mechanical analysis (DMA) at week 4 of culture, and com-
pared to chicken and calf articular cartilage (Figure 8). The elastic component  
(G′, storage modulus) of scaffolds and 3D cultures was significantly lower than 
values of chicken and calf cartilage. Regarding the viscous component (G″, loss 
modulus), 3D constructs differed from calf native cartilage, while only PCL cellular 
scaffolds presented differences with chicken cartilage. All samples presented G′ val-
ues higher than G″ values, meaning that the material was more elastic than viscous. 
Because the complex modulus (G*) is the sum of both components, G* basically 
corresponds to the elastic component in this case and it presented the same pattern 
as the storage modulus (G′). Concerning tan(delta), which is the full mechanical 
response of the material, the scaffolds and cell constructs were closely related to 
both native cartilages, with exception of RAD constructs in chondrogenic medium, 
which presented differences with calf cartilage. Moreover, differences were 
observed between PCL/RAD and RAD constructs under the same medium. The 
combination of PCL scaffold and RAD hydrogel changed their viscoelastic nature 
after 4 weeks of culture with hACh, since tan(delta) values of the composite were 
increased compared to RAD scaffolds alone. This effect was not observed between 
composites PCL/RAD and PCL scaffold alone.
In the present study we report the chondrogenic capacity of dedifferenti-
ated hACh in a composite scaffold comprising a microscale woven 3D poly 
(ε-caprolactone) and the peptide nanofiber scaffold RAD16-I. PCL scaffold resem-
bles native cartilage mechanical properties while the RAD16-I hydrogel provides a 
soft and permissive 3D environment. The expression of chondrogenic markers such 
Figure 8. 
Mechanical characterization of scaffolds alone and 3D constructs cultured for 4 weeks in expansion, control 
and chondrogenic medium compared to chicken and calf articular cartilage. hACh cultured in PCL, PCL/
RAD and RAD scaffolds were analyzed for storage modulus (G′), loss modulus (G″), complex modulus (G*) 
and tan(delta). Significant differences are indicated as * for p < 0.05, ** for p < 0.01, and *** for p < 0.001, 
one-way ANOVA, N = 2 n = 3). Adapted from Recha-Sancho et al. [46].
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as COL2 and ACAN was increased in the presence of RAD16-I peptide (in the com-
posite and alone) compared to 2D cultures (Figure 7A). At protein level, different 
band patterns were detected for COL1, fact that suggests a protein maturation 
process. Specifically, the scaffolds PCL/RAD and RAD alone under chondrogenic 
induction, expressed higher levels of the mature COL1, as evidenced by the inten-
sity of the 130 kDa band. Moreover, COL2 was only detected in PCL/RAD and 
RAD scaffolds under chondrogenic medium, suggesting that the expression of this 
cartilage-specific protein was due to the presence of RAD16-I hydrogel (Figure 7B). 
GAG production and accumulation was confirmed by toluidine blue staining in 
constructs under chondrogenic medium (Figure 7C). Finally, mechanical charac-
terization showed that at the end of culture, all constructs had a viscoelastic nature 
(tan delta) similar to native articular cartilage, even though G′ values differed sev-
eral folds from native cartilage (Figure 8). In resume, is clear that the combination 
of biomaterials to obtain a multi-dimensional composite (microfiber and nanofiber 
scales) is essential to acquire the best culture conditions for the cells to undergo 
cartilage lineage differentiation.
4. Conclusions
We report evidences from our previous work which indicates the chondro-
inductive capacity of newly developed biomaterials including heparin-, chondroitin 
sulfate-, decorin-, and poly(ε-caprolactone)-based self-assembling peptide com-
posite scaffolds. In particular, we demonstrated that these biomimetic biomaterials 
fostered re-differentiation of expanded human articular chondrocytes as well as 
adipose-derived stem cells into chondrogenic lineage commitment. Moreover, both 
biological and biomechanical properties obtained of these cartilage substitutes were 
comparable to natural samples of chicken and calf counterparts. This clearly sug-
gest that these newly class of biomaterials are promising for their future application 
in reparative and regenerative medicine platforms.
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